Dynamic Advisor Solutions LLC Takes Position in Laboratory Co. of America Holdings (NYSE:LH)

Dynamic Advisor Solutions LLC bought a new stake in shares of Laboratory Co. of America Holdings (NYSE:LHFree Report) during the 4th quarter, according to its most recent filing with the SEC. The fund bought 960 shares of the medical research company’s stock, valued at approximately $216,000.

Several other institutional investors have also made changes to their positions in the business. Eagle Bay Advisors LLC bought a new position in Laboratory Co. of America during the 2nd quarter valued at about $29,000. Provence Wealth Management Group bought a new position in Laboratory Co. of America during the 3rd quarter valued at about $29,000. Tradewinds Capital Management LLC bought a new position in shares of Laboratory Co. of America in the third quarter worth about $34,000. ST Germain D J Co. Inc. bought a new position in shares of Laboratory Co. of America in the second quarter worth about $43,000. Finally, Exchange Traded Concepts LLC bought a new position in shares of Laboratory Co. of America in the third quarter worth about $37,000. 89.37% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In related news, CFO Glenn A. Eisenberg sold 34,504 shares of the company’s stock in a transaction dated Wednesday, February 21st. The shares were sold at an average price of $215.97, for a total value of $7,451,828.88. Following the transaction, the chief financial officer now directly owns 23,595 shares in the company, valued at $5,095,812.15. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. In related news, CFO Glenn A. Eisenberg sold 34,504 shares of the company’s stock in a transaction dated Wednesday, February 21st. The shares were sold at an average price of $215.97, for a total value of $7,451,828.88. Following the transaction, the chief financial officer now directly owns 23,595 shares in the company, valued at $5,095,812.15. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CMO Amy B. Summy sold 227 shares of the company’s stock in a transaction dated Thursday, March 7th. The shares were sold at an average price of $218.45, for a total transaction of $49,588.15. Following the completion of the transaction, the chief marketing officer now owns 3,859 shares in the company, valued at $842,998.55. The disclosure for this sale can be found here. Insiders have sold 40,775 shares of company stock valued at $8,823,080 over the last ninety days. 0.65% of the stock is currently owned by company insiders.

Laboratory Co. of America Stock Up 0.2 %

Laboratory Co. of America stock opened at $213.75 on Tuesday. The stock has a market capitalization of $17.98 billion, a PE ratio of 45.77, a price-to-earnings-growth ratio of 1.61 and a beta of 1.02. Laboratory Co. of America Holdings has a twelve month low of $174.20 and a twelve month high of $234.09. The company has a quick ratio of 1.02, a current ratio of 1.17 and a debt-to-equity ratio of 0.52. The company has a 50 day moving average of $219.58 and a 200-day moving average of $213.93.

Laboratory Co. of America (NYSE:LHGet Free Report) last released its quarterly earnings results on Thursday, February 15th. The medical research company reported $3.30 earnings per share for the quarter, beating the consensus estimate of $3.29 by $0.01. The company had revenue of $3.03 billion during the quarter, compared to analysts’ expectations of $3.02 billion. Laboratory Co. of America had a net margin of 3.24% and a return on equity of 13.99%. The business’s quarterly revenue was down 17.5% compared to the same quarter last year. During the same quarter in the prior year, the company earned $4.14 earnings per share. On average, equities research analysts anticipate that Laboratory Co. of America Holdings will post 14.77 EPS for the current fiscal year.

Laboratory Co. of America Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, March 13th. Stockholders of record on Tuesday, February 27th were given a $0.72 dividend. This represents a $2.88 annualized dividend and a dividend yield of 1.35%. The ex-dividend date of this dividend was Monday, February 26th. Laboratory Co. of America’s payout ratio is presently 61.67%.

Wall Street Analysts Forecast Growth

A number of equities analysts have weighed in on the stock. Leerink Partnrs reaffirmed an “outperform” rating on shares of Laboratory Co. of America in a research note on Monday, February 26th. Evercore ISI assumed coverage on shares of Laboratory Co. of America in a research note on Friday, February 9th. They issued an “in-line” rating and a $240.00 target price for the company. Barclays began coverage on shares of Laboratory Co. of America in a research note on Wednesday, January 3rd. They issued an “equal weight” rating and a $222.00 target price for the company. TheStreet cut shares of Laboratory Co. of America from a “b-” rating to a “c+” rating in a research report on Thursday, February 15th. Finally, SVB Leerink began coverage on shares of Laboratory Co. of America in a research report on Monday, February 26th. They set an “outperform” rating and a $260.00 price target for the company. Four analysts have rated the stock with a hold rating and eleven have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $243.50.

Get Our Latest Report on LH

Laboratory Co. of America Company Profile

(Free Report)

Laboratory Corporation of America Holdings operates as a life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Biopharma Laboratory Services (BLS).

Further Reading

Want to see what other hedge funds are holding LH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Laboratory Co. of America Holdings (NYSE:LHFree Report).

Institutional Ownership by Quarter for Laboratory Co. of America (NYSE:LH)

Receive News & Ratings for Laboratory Co. of America Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Laboratory Co. of America and related companies with MarketBeat.com's FREE daily email newsletter.